Health insurers offer coverage for pre-existing diseases like diabetes, hypertension, and asthma from Day 1. Key features ...

Looking for herbs that can lower your blood pressure? In this video, we'll show you a list of herbs that can help to lower your blood pressure. Herbal medicine is a great way to find relief from ...

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

University Hospital at Downstate in Brooklyn faces many of the problems plaguing other medical centers in New York, but the ...

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

June 11, 2025 – The FDA has approved a new pill for adults with high blood pressure (hypertension) that combines three medicines in one. Available in one regular and two lower doses, it offers a ...

A new era of hypertension treatment is on the horizon for U.S. patients with the FDA approval of George Medicines’ Widaplik, a three-in-one pill that can serve as an initial treatment to help ...

George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment ...

The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the results of two positive studies presented at the European Society of Cardiology Congress.

A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with uncontrolled or resistant hypertension, a global phase 3 trial showed.

The data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, show that lorundrostat, an aldosterone synthase inhibitor, is a safe and ...